These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17965585)

  • 1. Expression and function of transmembrane-4 superfamily (tetraspanin) proteins in osteoclasts: reciprocal roles of Tspan-5 and NET-6 during osteoclastogenesis.
    Iwai K; Ishii M; Ohshima S; Miyatake K; Saeki Y
    Allergol Int; 2007 Dec; 56(4):457-63. PubMed ID: 17965585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis.
    Ishii M; Iwai K; Koike M; Ohshima S; Kudo-Tanaka E; Ishii T; Mima T; Katada Y; Miyatake K; Uchiyama Y; Saeki Y
    J Bone Miner Res; 2006 Jun; 21(6):965-76. PubMed ID: 16753027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
    Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
    J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Notch modulators, tetraspanin 5 and 10, inhibits osteoclastogenesis in vitro.
    Zhou J; Fujiwara T; Ye S; Li X; Zhao H
    Calcif Tissue Int; 2014 Sep; 95(3):209-217. PubMed ID: 24935633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin CD9 regulates osteoclastogenesis via regulation of p44/42 MAPK activity.
    Yi T; Kim HJ; Cho JY; Woo KM; Ryoo HM; Kim GS; Baek JH
    Biochem Biophys Res Commun; 2006 Aug; 347(1):178-84. PubMed ID: 16808899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration.
    Ishida N; Hayashi K; Hattori A; Yogo K; Kimura T; Takeya T
    J Bone Miner Res; 2006 Jan; 21(1):48-57. PubMed ID: 16355273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts.
    Brazier H; Stephens S; Ory S; Fort P; Morrison N; Blangy A
    J Bone Miner Res; 2006 Sep; 21(9):1387-98. PubMed ID: 16939397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast cell fusion: mechanisms and molecules.
    Ishii M; Saeki Y
    Mod Rheumatol; 2008; 18(3):220-7. PubMed ID: 18425565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
    Egusa H; Doi M; Saeki M; Fukuyasu S; Akashi Y; Yokota Y; Yatani H; Kamisaki Y
    Bone; 2011 Aug; 49(2):264-74. PubMed ID: 21504804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
    Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
    J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.
    Takeda Y; Tachibana I; Miyado K; Kobayashi M; Miyazaki T; Funakoshi T; Kimura H; Yamane H; Saito Y; Goto H; Yoneda T; Yoshida M; Kumagai T; Osaki T; Hayashi S; Kawase I; Mekada E
    J Cell Biol; 2003 Jun; 161(5):945-56. PubMed ID: 12796480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells.
    Kameyama S; Yoshimura Y; Kameyama T; Kikuiri T; Matsuno M; Deyama Y; Suzuki K; Iida J
    Int J Mol Med; 2013 Feb; 31(2):292-8. PubMed ID: 23292096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.